Aster DM Healthcare Ltd is an India-based company that engages in the provision of healthcare solutions. The company operates in multiple business divisions of the involved in the operations of healthcare facilities, retail pharmacies, and providing consultancy in areas relating to healthcare. Its segments are Hospitals, Clinics, Retail pharmacies and others, of which key revenue is derived from the Hospitals segment The company conducts operations in all GCC states, comprising of United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain; India, and Republic of Mauritius.
2008
1.6K+
LTM Revenue $510M
LTM EBITDA $96.3M
$3.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Aster DM Healthcare has a last 12-month revenue (LTM) of $510M and a last 12-month EBITDA of $96.3M.
In the most recent fiscal year, Aster DM Healthcare achieved revenue of $484M and an EBITDA of $99.4M.
Aster DM Healthcare expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Aster DM Healthcare valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $510M | XXX | $484M | XXX | XXX | XXX |
Gross Profit | $384M | XXX | $374M | XXX | XXX | XXX |
Gross Margin | 75% | XXX | 77% | XXX | XXX | XXX |
EBITDA | $96.3M | XXX | $99.4M | XXX | XXX | XXX |
EBITDA Margin | 19% | XXX | 21% | XXX | XXX | XXX |
EBIT | $68.1M | XXX | $60.3M | XXX | XXX | XXX |
EBIT Margin | 13% | XXX | 12% | XXX | XXX | XXX |
Net Profit | $42.5M | XXX | $629M | XXX | XXX | XXX |
Net Margin | 8% | XXX | 130% | XXX | XXX | XXX |
Net Debt | XXX | XXX | $55.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 18, 2025, Aster DM Healthcare's stock price is INR 594 (or $7).
Aster DM Healthcare has current market cap of INR 307B (or $3.6B), and EV of INR 312B (or $3.7B).
See Aster DM Healthcare trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$3.7B | $3.6B | XXX | XXX | XXX | XXX | $0.09 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 18, 2025, Aster DM Healthcare has market cap of $3.6B and EV of $3.7B.
Aster DM Healthcare's trades at 7.8x EV/Revenue multiple, and 32.0x EV/EBITDA.
Equity research analysts estimate Aster DM Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Aster DM Healthcare has a P/E ratio of 84.4x.
See valuation multiples for Aster DM Healthcare and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $3.6B | XXX | $3.6B | XXX | XXX | XXX |
EV (current) | $3.7B | XXX | $3.7B | XXX | XXX | XXX |
EV/Revenue | 7.2x | XXX | 7.8x | XXX | XXX | XXX |
EV/EBITDA | 37.9x | XXX | 32.0x | XXX | XXX | XXX |
EV/EBIT | 53.6x | XXX | 65.3x | XXX | XXX | XXX |
EV/Gross Profit | 9.5x | XXX | n/a | XXX | XXX | XXX |
P/E | 84.4x | XXX | 7.6x | XXX | XXX | XXX |
EV/FCF | 120.4x | XXX | -282.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAster DM Healthcare's last 12 month revenue growth is 19%
Aster DM Healthcare's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Aster DM Healthcare's rule of 40 is 43% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Aster DM Healthcare's rule of X is 65% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Aster DM Healthcare and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 19% | XXX | 18% | XXX | XXX | XXX |
EBITDA Margin | 19% | XXX | 24% | XXX | XXX | XXX |
EBITDA Growth | 25% | XXX | 8% | XXX | XXX | XXX |
Rule of 40 | 43% | XXX | 43% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 65% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 65% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aster DM Healthcare acquired XXX companies to date.
Last acquisition by Aster DM Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Aster DM Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Aster DM Healthcare founded? | Aster DM Healthcare was founded in 2008. |
Where is Aster DM Healthcare headquartered? | Aster DM Healthcare is headquartered in India. |
How many employees does Aster DM Healthcare have? | As of today, Aster DM Healthcare has 1.6K+ employees. |
Is Aster DM Healthcare publicy listed? | Yes, Aster DM Healthcare is a public company listed on BOM. |
What is the stock symbol of Aster DM Healthcare? | Aster DM Healthcare trades under 540975 ticker. |
When did Aster DM Healthcare go public? | Aster DM Healthcare went public in 2018. |
Who are competitors of Aster DM Healthcare? | Similar companies to Aster DM Healthcare include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of Aster DM Healthcare? | Aster DM Healthcare's current market cap is $3.6B |
What is the current revenue of Aster DM Healthcare? | Aster DM Healthcare's last 12 months revenue is $510M. |
What is the current revenue growth of Aster DM Healthcare? | Aster DM Healthcare revenue growth (NTM/LTM) is 19%. |
What is the current EV/Revenue multiple of Aster DM Healthcare? | Current revenue multiple of Aster DM Healthcare is 7.2x. |
Is Aster DM Healthcare profitable? | Yes, Aster DM Healthcare is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Aster DM Healthcare? | Aster DM Healthcare's last 12 months EBITDA is $96.3M. |
What is Aster DM Healthcare's EBITDA margin? | Aster DM Healthcare's last 12 months EBITDA margin is 19%. |
What is the current EV/EBITDA multiple of Aster DM Healthcare? | Current EBITDA multiple of Aster DM Healthcare is 37.9x. |
What is the current FCF of Aster DM Healthcare? | Aster DM Healthcare's last 12 months FCF is $30.3M. |
What is Aster DM Healthcare's FCF margin? | Aster DM Healthcare's last 12 months FCF margin is 6%. |
What is the current EV/FCF multiple of Aster DM Healthcare? | Current FCF multiple of Aster DM Healthcare is 120.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.